drugset / Trial / NCT01479114

Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on CD11b in Septic Neonates

NCT01479114

Phase 4 Completed 90 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators aimed to evaluate the effect of G-CSF administration in septic neonates on neutrophil production and CD11b expression.

Timeline

Start
2009-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic 10 ug/kg Intravenous

Indications